BIO-KEY INTERNATIONAL INC (BKYI)

US09060C5076 - Common Stock

2.1005  +0.69 (+48.97%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
5.11M
79.93%
7.02M
37.38%
7.755M
10.47%
7.907M
1.96%
8.67M
9.65%
EBITDA
YoY % growth
-4.66M
6.61%
-7.64M
-63.95%
-8.397M
-9.90%
N/AN/A
EBIT
YoY % growth
-4.94M
5.00%
-8.03M
-62.55%
-8.826M
-9.92%
-3.111M
64.75%
-2.917M
6.23%
Operating Margin
-96.67%-114.39%-113.82%-39.34%-33.65%
EPS
YoY % growth
-0.63
76.32%
-7.82
-1,141.27%
N/A
88.65%
-1.90
-113.79%
-1.59
16.13%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.36
-105.88%
Revenue
Q2Q % growth
2.336M
152.51%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-622.2K
90.46%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.39
-91.18%
-0.590.2034.08%
Q2 2024
Q2Q % growth
-1.00
65.28%
-0.55-0.45-81.55%
Q4 2023
Q2Q % growth

97.59%
-0.17%
Q3 2023
Q2Q % growth

29.66%
-0.20%
Q2 2023
Q2Q % growth
-2.88
-1,271.43%
-4.221.3431.80%
Q1 2023
Q2Q % growth
-1.44
-1,100.00%
-4.963.5270.95%
Q4 2022
Q2Q % growth
-7.20
-2,669.23%
-4.96-2.24-45.24%
Q3 2022
Q2Q % growth
-0.29
-123.08%
-0.16-0.13-77.70%
Q2 2022
Q2Q % growth
-0.21
-40.00%
-0.08-0.13-157.35%
Q1 2022
Q2Q % growth
-0.12
-33.33%
-0.220.1046.52%
Q4 2021
Q2Q % growth
-0.26
-44.44%
-0.15-0.11-69.93%
Q3 2021
Q2Q % growth
-0.13
72.92%
-0.11-0.02-15.86%
Q2 2021
Q2Q % growth
-0.15
73.21%
-0.11-0.04-33.69%
Q1 2021
Q2Q % growth
-0.09
93.75%
-0.160.0744.85%
Q4 2020
Q2Q % growth
-0.18
86.76%
-0.16-0.02-10.29%
Q3 2020
Q2Q % growth
-0.48
53.85%
-0.08-0.40-488.24%
Q2 2020
Q2Q % growth
-0.56 -0.24-0.32-128.76%
Q1 2020
Q2Q % growth
-1.44
-38.46%
-0.41-1.03-252.94%
Q4 2019
Q2Q % growth
-1.36
-70.00%
-0.24-1.12-455.56%
Q3 2019
Q2Q % growth
-1.04
-8.33%
-0.41-0.63-154.90%
Q2 2019
Q2Q % growth
-0.56
53.33%
-0.41-0.15-37.25%
Q1 2019
Q2Q % growth
-1.04
56.67%
-0.33-0.71-218.63%
Q4 2018
Q2Q % growth
-0.80 0.49-1.29-263.40%
Q2 2018
Q2Q % growth
-1.20 -0.49-0.71-145.10%
Q1 2018
Q2Q % growth
-2.40 -1.63-0.77-47.06%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.145M
18.03%
1.632M512.8K31.42%
Q2 2024
Q2Q % growth
1.141M
-40.80%
1.989M-847.71K-42.62%
Q1 2024
Q2Q % growth
2.181M
-29.25%
%
Q4 2023
Q2Q % growth
925.1K
-47.44%
3.213M-2.288M-71.21%
Q3 2023
Q2Q % growth
1.817M
32.64%
2.601M-783.89K-30.14%
Q2 2023
Q2Q % growth
1.928M
-1.13%
2.346M-418K-17.82%
Q1 2023
Q2Q % growth
3.083M
58.92%
2.04M1.043M51.13%
Q4 2022
Q2Q % growth
1.76M
89.25%
1.775M-15K-0.85%
Q3 2022
Q2Q % growth
1.37M
5.38%
2.448M-1.078M-44.04%
Q2 2022
Q2Q % growth
1.95M
96.97%
2.55M-600K-23.53%
Q1 2022
Q2Q % growth
1.94M
2.65%
1.275M665K52.16%
Q4 2021
Q2Q % growth
930K
-12.26%
1.428M-498K-34.87%
Q3 2021
Q2Q % growth
1.3M
38.30%
1.53M-230K-15.03%
Q2 2021
Q2Q % growth
990K
219.35%
1.734M-744K-42.91%
Q1 2021
Q2Q % growth
1.89M
263.46%
1.275M615K48.24%
Q4 2020
Q2Q % growth
1.06M
100.00%
1.377M-317K-23.02%
Q3 2020
Q2Q % growth
940K
108.89%
928.2K11.8K1.27%
Q2 2020
Q2Q % growth
310K
-57.53%
1.601M-1.291M-80.64%
Q1 2020
Q2Q % growth
520K
-5.45%
1.561M-1.041M-66.69%
Q4 2019
Q2Q % growth
530K
-69.19%
3.335M-2.805M-84.11%
Q3 2019
Q2Q % growth
450K
-39.19%
1.693M-1.243M-73.42%
Q2 2019
Q2Q % growth
730K
-2.67%
836.4K-106.4K-12.72%
Q1 2019
Q2Q % growth
550K
-34.52%
1.938M-1.388M-71.62%
Q4 2018
Q2Q % growth
1.72M 5.988M-4.268M-71.28%
Q3 2018
Q2Q % growth
740K 1.952M-1.212M-62.09%
Q2 2018
Q2Q % growth
750K 2.04M-1.29M-63.24%
Q1 2018
Q2Q % growth
840K 1.02M-180K-17.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0% 16.59%
Revenue0% N/A 0% 13.67%